SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Mochida Initiates Phase III Study of BON-001 in Japan

Mochida Pharmaceutical has initiated a Phase III clinical study of BON-001 for nausea and vomiting of pregnancy in Japan.

Related stories